EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection



Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection



Virus Genes 1(1): 73-82



Two infection systems have been introduced in order to study viral gene expression at the initial period of Epstein-Barr virus (EBV) infection which leads to immortalization. The data indicate that major viral gene expression in tonsil lymphocytes at 2 days post-infection (p.i.) with EBV is very similar to that observed in latently infected cells. Both tonsil lymphocyte and BJAB cell (lymphoblastoid cells free of EBV genome) infection with EBV induced similar viral gene transcription. Twelve cDNA clones were prepared from poly(A) RNA of tonsil lymphocytes infected with EBV 2 days p.i. by hybridization with BamHI fragments of EBV DNA. Some cDNAs were derived from primary transcripts of the BamHI-WYHK region, suggestive of splicing of a large transcript. It is possible that a number of cDNA clones may be derived from cellular genes. The derivation of these cDNA clones is being studied.

(PDF emailed within 0-6 h: $19.90)

Accession: 039793027

Download citation: RISBibTeXText

PMID: 2854323

DOI: 10.1007/bf00125687



Related references

Transcription of the Epstein-Barr virus nuclear antigen 1 gene occurs before induction of the BCR2 EBNA gene promoter during the initial stages of infection in B cells. Journal of Virology 70(6): 3561-3570, 1996

Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. Journal of Virology 70(6): 3561-3570, 1996

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Treatment of Epstein-Barr virus -associated lymphomas and PTLD using Arginine Butyrate to induce viral TK gene expression Initial findings of a phase I/II trial. Blood 94(10 SUPPL 1 PART 1): 523a, Nov 15, 1999

Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology 68(11): 7374-7385, 1994

Infection of mouse lymphocytes by epstein barr virus 2 stimulation of cellular dna synthesis by epstein barr virus in the absence of epstein barr virus determined nuclear antigen induction and cell transformation. 1984

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

An epstein barr virus genome negative cell line established from an american burkitts lymphoma receptor characteristics epstein barr virus infectibility and permanent conversion into epstein barr virus positive sublines by in vitro infection. Intervirology 5(6): 319-334, 1975

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Aids 21(16): 2141-2149, 2007

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study. Clinical Immunology 119(1): 79-86, 2006

Production by epstein barr virus infection of an epstein barr nuclear antigen positive subline from an epstein barr nuclear antigen negative human lymphoma cell line without detectable epstein barr virus dna. International Journal of Cancer 16(1): 125-133, 1975

Documentation of epstein barr virus infection in immuno deficient patients with life threatening lympho proliferative diseases by epstein barr virus complementary rna dna and viral dna dna hybridization. Cancer Research 41(11 PART 1): 4237-4242, 1981

Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection. Journal of Clinical Virology 50(2): 184-185, 2011

Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma. Leukemia & Lymphoma 56(4): 1072-1078, 2016